摘要
目的探讨β-二酮钴的配合物抑制人胶质瘤细胞U251增殖的机制。方法彳F经10、25mg/L β-二酮钴的配合物处理48h后人胶质瘤细胞U251中,通过光镜观察细胞形态变化,噻唑监(MTT)法分析细胞存活力变化;流式细胞术分析经10、25mg/L β-二酮钴的配合物处理48h后细胞周期的变化;最后通过Westernblot分析10、25mg/L β-二酮钴的配合物处理24h后周期相关蛋白的表达变化。结果13-二酮钻的配合物抑制人胶质瘤细胞U251增殖并呈现剂量依赖性,半数抑制剂置(IC50)值为(25.30±4.22)mg/L,10%抑制剂量(IC10值为(6.61±2.42)mg/L且抑制效果渺簧强于5-氟尿嘧啶(5-Fu);β-二酮钴的配合物诱导U25l细胞发生S期阻滞,并呈现剂量依赖性;β-二酮钴的配合物诱导U251细胞周期蛋白(Cyclin)A和周期蛋白依赖性蛋白激酶2(CDK2)蛋白的表达下调,p21蛋白表达上调。结论β-二酮钻的配合物抑制胶质瘤细胞U251是通过诱导细胞川期S期阻滞实现的。
Objective To investigate the mechanisms by which β- diketone - cobalt complexes inhibited human glioma U251 cells. Methods After treatment with β- diketone - cobalt complexes ( 10, 25 mg/L) for 48 h, human glioma U251 cells were observed on the morphologies, analyzed with methyl th- iazol tetrazolium (MTT) assay for cell proliferation, and assessed for the changes of cell cycle by flow cy- lometry. After treatment with β- diketone - cobalt complexes ( 10, 25 mg/L) for 24 h, Western blotting was used to identify proteins involved in cell cycle. Results β- diketone - cobalt complexes suppressed human glioma U251 cells viability in a dose -dependent manner. 50% inhibitory dose (IC50) of β-dike- tone - cobalt complexes was ( 25.30 ± 4. 22 ) mg/L, and 10% inhibitory dose ( IC10 ) was ( 6. 61±2.42) mg/L. β-diketone- cobalt complexes induced S arrest in U251 cells, increased the p21 and deereased cyclin A and cyclin-dependent kinase 2 (CDK2) expression. Conclusion β-diketone - cobalt complexes show an inhibitory effect against human glioma U251 cells by inducing the S arrest of cell cycle.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2015年第8期1922-1924,共3页
Chinese Journal of Experimental Surgery
基金
吉林省财政厅省商卫生专项项目(SCZSY201511)
古林省科技厅青年科研基金项目(20130522040-IH)